Cube Biotech GmbH is a leading German biotechnology company focused on providing innovative solutions for protein biochemistry. They specialize in the expression, purification, and stabilization of proteins, with particular expertise in challenging membrane proteins. Key offerings include the proprietary Strep-tag® technology, a wide range of purification resins (e.g., Ni-NTA, Glutathione, Protein A/G), specialized detergents, and custom protein services including expression, purification, and assay development. Cube Biotech supports researchers and industries worldwide in advancing their protein-related projects, from basic research to drug discovery.
The headquarters serves as the central hub for Cube Biotech's research and development, manufacturing of protein purification products, custom protein services, quality control, and corporate administration.
Located in the Creative Campus Monheim, a modern business park fostering innovation and collaboration among technology-focused companies. Facilities are designed to support advanced biotechnological research, development, and production.
Cube Biotech fosters a scientifically driven and innovative work environment, emphasizing collaboration, precision, and a commitment to high-quality research and product development. The culture supports expertise in protein biochemistry and customer-focused solutions.
The Monheim am Rhein headquarters is crucial as it centralizes Cube Biotech's core operations, from R&D and product innovation (like Strep-tag® technology) to manufacturing and global customer support, enabling its role as a specialist in protein biochemistry.
Cube Biotech GmbH serves a global customer base from its headquarters in Germany, supported by a comprehensive network of international distributors. This network facilitates the worldwide supply of their specialized protein purification products, technologies like Strep-tag®, and custom services to academic institutions, research organizations, and biotechnology/pharmaceutical companies across Europe, North America, Asia, Australia, and other regions. Their global reach ensures researchers worldwide have access to their innovative solutions for protein biochemistry.
Alfred-Nobel-Str. 10
Monheim am Rhein
North Rhine-Westphalia
Germany
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Cube Biotech' leadership includes:
Cube Biotech has been backed by several prominent investors over the years, including:
Following QIAGEN's acquisition of a majority stake in July 2023, the core leadership team of Cube Biotech GmbH has largely remained consistent. No other specific major executive hires or departures have been publicly announced in the past 12 months.
Discover the tools Cube Biotech uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Cube Biotech GmbH likely utilizes common professional email formats. While individual email addresses are not broadly publicized, general contact is facilitated through forms and central email addresses on their website. A common pattern for German companies is [first_initial].[last_name]@[company_domain] or [first_name].[last_name]@[company_domain].
[first_initial].[last_name]@cube-biotech.com
Format
t.koegl@cube-biotech.com
Example
75%
Success rate
Cube Biotech Website News • October 19, 2023
Cube Biotech announced the availability of new PureCube Compact Cartridges, designed for convenient and efficient small-scale protein purification using FPLC systems. These pre-packed cartridges are available with various affinity matrices....more
QIAGEN Press Release • July 27, 2023
QIAGEN N.V. announced it has acquired a 96% majority stake in Cube Biotech GmbH, a German company specializing in innovative sample preparation solutions for challenging proteins, particularly membrane proteins. The acquisition strengthens QIAGEN's portfolio in protein research and drug discovery....more
Cube Biotech Website News • November 2, 2023
Cube Biotech confirmed its participation and exhibition at the PEGS Europe Summit in Lisbon (November 14-16, 2023), showcasing its latest products and services for protein expression and purification to the European protein engineering community....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Cube Biotech, are just a search away.